This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Alejandro Carpy
Group Leader at Roche


Dr. Alejandro Carpy  is a Senior Scientist and Group Leader at Large Molecule Research in pharma  Research and Early Development (pRED) at the Roche Innovation Center Munich.  Among his responsibilities are the molecular assessment, analytical method  development and method handover to the technical development function and the  in-depth biophysical characterization of therapeutic antibodies and next  generation biologics. He is involved in defining the analytical  characterization strategy for several next generation biologics projects. He  holds a PhD in Biochemistry from the University of Tübingen (Germany). Before  joining Roche, he started his career at Novartis and worked at diverse sites  gaining cross-functional experience in Quality, Production and Development.

Agenda Sessions

  • High throughput Developability Assessments To Reduce Timelines